Various aspects of the relationship between vitiligo and the COVID-19 pandemic or SARS-CoV-2 vaccines: Clinical pearls for dermatologists.

Autor: Aryanian Z; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Babol University of Medical Sciences, Babol, Iran., Balighi K; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Hatami P; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Goodarzi A; Department of Dermatology, Rasoul-e- Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.; Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran., Janbakhsh A; Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran., Afshar ZM; Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Jazyk: angličtina
Zdroj: Journal of cosmetic dermatology [J Cosmet Dermatol] 2023 Apr; Vol. 22 (4), pp. 1152-1156. Date of Electronic Publication: 2023 Feb 09.
DOI: 10.1111/jocd.15550
Abstrakt: Background: Coronavirus disease 2019 (COVID-19) has given rise to several new onset or exacerbated dermatologic disorders including vitiligo.
Aim and Method: Here, we present different aspects of relationship between SARS-CoV-2 infection or its associated vaccines and vitiligo and aim to provide solutions to overcome the potential challenges.
Results and Conclusion: In brief, as the benefits overweigh the risks and since vaccine-triggered de novo or flares of vitiligo are uncommon and benign, these patients are recommended to get SARS-CoV-2 vaccines. Moreover, in individuals with previously recognized vitiligo, who are at risk of developing SARS-CoV-2 infection or those who are currently infected, special dermatologic consultation is needed in order to balance the immunosuppressive agents in their therapeutic regimen to prevent COVID-related morbidity and mortality.
(© 2022 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje